Small molecule AKAP-Protein Kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes

Frank Christian, Márta Szaszák, Sabine Friedl, Stephan Drewianka, Dorothea Lorenz, Andrey Goncalves, Jens Furkert, Carolyn Vargas, Peter Schmieder, Frank Götz, Kerstin Zühlke, Marie Moutty, Hendrikje Göttert, Mangesh Joshi, Bernd Reif, Hannelore Haase, Ingo Morano, Solveig Grossmann, Anna Klukovits, Judit Verli & 16 others R. Gáspár, Claudia Noack, Martin Bergmann, Robert Kass, Kornelia Hampel, Dmitry Kashin, Hans Gottfried Genieser, Friedrich W. Herberg, Debbie Willoughby, Dermot M F Cooper, George S. Baillie, Miles D. Houslay, Jens Peter Von Kries, Bastian Zimmermann, Walter Rosenthal, Enno Klussmann

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3′-diamino-4,4′- dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating β-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMPAPI-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.

Original languageEnglish
Pages (from-to)9079-9096
Number of pages18
JournalJournal of Biological Chemistry
Volume286
Issue number11
DOIs
Publication statusPublished - Mar 18 2011

Fingerprint

Cyclic AMP-Dependent Protein Kinases
Cardiac Myocytes
Protein Kinases
Phosphotransferases
Application programming interfaces (API)
Molecules
Proteins
Allosteric Site
Rats
Heart Failure
N-formylmethionylphenylalanine
Derivatives

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Small molecule AKAP-Protein Kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. / Christian, Frank; Szaszák, Márta; Friedl, Sabine; Drewianka, Stephan; Lorenz, Dorothea; Goncalves, Andrey; Furkert, Jens; Vargas, Carolyn; Schmieder, Peter; Götz, Frank; Zühlke, Kerstin; Moutty, Marie; Göttert, Hendrikje; Joshi, Mangesh; Reif, Bernd; Haase, Hannelore; Morano, Ingo; Grossmann, Solveig; Klukovits, Anna; Verli, Judit; Gáspár, R.; Noack, Claudia; Bergmann, Martin; Kass, Robert; Hampel, Kornelia; Kashin, Dmitry; Genieser, Hans Gottfried; Herberg, Friedrich W.; Willoughby, Debbie; Cooper, Dermot M F; Baillie, George S.; Houslay, Miles D.; Von Kries, Jens Peter; Zimmermann, Bastian; Rosenthal, Walter; Klussmann, Enno.

In: Journal of Biological Chemistry, Vol. 286, No. 11, 18.03.2011, p. 9079-9096.

Research output: Contribution to journalArticle

Christian, F, Szaszák, M, Friedl, S, Drewianka, S, Lorenz, D, Goncalves, A, Furkert, J, Vargas, C, Schmieder, P, Götz, F, Zühlke, K, Moutty, M, Göttert, H, Joshi, M, Reif, B, Haase, H, Morano, I, Grossmann, S, Klukovits, A, Verli, J, Gáspár, R, Noack, C, Bergmann, M, Kass, R, Hampel, K, Kashin, D, Genieser, HG, Herberg, FW, Willoughby, D, Cooper, DMF, Baillie, GS, Houslay, MD, Von Kries, JP, Zimmermann, B, Rosenthal, W & Klussmann, E 2011, 'Small molecule AKAP-Protein Kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes', Journal of Biological Chemistry, vol. 286, no. 11, pp. 9079-9096. https://doi.org/10.1074/jbc.M110.160614
Christian, Frank ; Szaszák, Márta ; Friedl, Sabine ; Drewianka, Stephan ; Lorenz, Dorothea ; Goncalves, Andrey ; Furkert, Jens ; Vargas, Carolyn ; Schmieder, Peter ; Götz, Frank ; Zühlke, Kerstin ; Moutty, Marie ; Göttert, Hendrikje ; Joshi, Mangesh ; Reif, Bernd ; Haase, Hannelore ; Morano, Ingo ; Grossmann, Solveig ; Klukovits, Anna ; Verli, Judit ; Gáspár, R. ; Noack, Claudia ; Bergmann, Martin ; Kass, Robert ; Hampel, Kornelia ; Kashin, Dmitry ; Genieser, Hans Gottfried ; Herberg, Friedrich W. ; Willoughby, Debbie ; Cooper, Dermot M F ; Baillie, George S. ; Houslay, Miles D. ; Von Kries, Jens Peter ; Zimmermann, Bastian ; Rosenthal, Walter ; Klussmann, Enno. / Small molecule AKAP-Protein Kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. In: Journal of Biological Chemistry. 2011 ; Vol. 286, No. 11. pp. 9079-9096.
@article{1468bb5a724d430a9cb9e2e0f1e0ca1f,
title = "Small molecule AKAP-Protein Kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes",
abstract = "A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3′-diamino-4,4′- dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating β-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMPAPI-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.",
author = "Frank Christian and M{\'a}rta Szasz{\'a}k and Sabine Friedl and Stephan Drewianka and Dorothea Lorenz and Andrey Goncalves and Jens Furkert and Carolyn Vargas and Peter Schmieder and Frank G{\"o}tz and Kerstin Z{\"u}hlke and Marie Moutty and Hendrikje G{\"o}ttert and Mangesh Joshi and Bernd Reif and Hannelore Haase and Ingo Morano and Solveig Grossmann and Anna Klukovits and Judit Verli and R. G{\'a}sp{\'a}r and Claudia Noack and Martin Bergmann and Robert Kass and Kornelia Hampel and Dmitry Kashin and Genieser, {Hans Gottfried} and Herberg, {Friedrich W.} and Debbie Willoughby and Cooper, {Dermot M F} and Baillie, {George S.} and Houslay, {Miles D.} and {Von Kries}, {Jens Peter} and Bastian Zimmermann and Walter Rosenthal and Enno Klussmann",
year = "2011",
month = "3",
day = "18",
doi = "10.1074/jbc.M110.160614",
language = "English",
volume = "286",
pages = "9079--9096",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "11",

}

TY - JOUR

T1 - Small molecule AKAP-Protein Kinase A (PKA) interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes

AU - Christian, Frank

AU - Szaszák, Márta

AU - Friedl, Sabine

AU - Drewianka, Stephan

AU - Lorenz, Dorothea

AU - Goncalves, Andrey

AU - Furkert, Jens

AU - Vargas, Carolyn

AU - Schmieder, Peter

AU - Götz, Frank

AU - Zühlke, Kerstin

AU - Moutty, Marie

AU - Göttert, Hendrikje

AU - Joshi, Mangesh

AU - Reif, Bernd

AU - Haase, Hannelore

AU - Morano, Ingo

AU - Grossmann, Solveig

AU - Klukovits, Anna

AU - Verli, Judit

AU - Gáspár, R.

AU - Noack, Claudia

AU - Bergmann, Martin

AU - Kass, Robert

AU - Hampel, Kornelia

AU - Kashin, Dmitry

AU - Genieser, Hans Gottfried

AU - Herberg, Friedrich W.

AU - Willoughby, Debbie

AU - Cooper, Dermot M F

AU - Baillie, George S.

AU - Houslay, Miles D.

AU - Von Kries, Jens Peter

AU - Zimmermann, Bastian

AU - Rosenthal, Walter

AU - Klussmann, Enno

PY - 2011/3/18

Y1 - 2011/3/18

N2 - A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3′-diamino-4,4′- dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating β-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMPAPI-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.

AB - A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3′-diamino-4,4′- dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating β-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMPAPI-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.

UR - http://www.scopus.com/inward/record.url?scp=79953189372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953189372&partnerID=8YFLogxK

U2 - 10.1074/jbc.M110.160614

DO - 10.1074/jbc.M110.160614

M3 - Article

VL - 286

SP - 9079

EP - 9096

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 11

ER -